Medium and large alleles of the PGC gene are risk factors for gastric cancer [0.03%]
PGC基因的中大等位基因是胃癌的风险因素
Josefina Yoaly Sánchez-López,Katia Carolina Vázquez-Ibarra,Andrea Marlene García-Muro et al.
Josefina Yoaly Sánchez-López et al.
Background: A 100-bp insertion/deletion polymorphism in the pepsinogen C gene has been associated with the risk of gastric cancer (GC). Objective: ...
Patterns of mutations in nine cancer-related genes and PAF development among smoking male patients diagnosed with bladder cancer [0.03%]
吸烟男性膀胱癌患者中九个癌症相关基因的突变特征及其与肺癌发生风险关联性分析
Eman Alshehri,Amal M Al-Dogmi,Tahani Mohamed Ibrahim Al-Hazani et al.
Eman Alshehri et al.
Background: Smoking is one of the most popular risk factors provoking bladder cancer (BC). This research intended to estimate cigarette smoking effect involving PAF signs between smoking patients with BC and non-smoking p...
Clinical perspectives on serum tumor marker use in predicting prognosis and treatment response in advanced non-small cell lung cancer [0.03%]
血清肿瘤标志物在晚期非小细胞肺癌预后及治疗反应中的临床应用展望
Alessandra I G Buma,Milou M F Schuurbiers,Huub H van Rossum et al.
Alessandra I G Buma et al.
The optimal positioning and usage of serum tumor markers (STMs) in advanced non-small cell lung cancer (NSCLC) care is still unclear. This review aimed to provide an overview of the potential use and value of STMs in routine advanced NSCLC ...
Predictive biomarkers for response to trametinib in non-small cell lung cancer [0.03%]
曲美替尼治疗非小细胞肺癌的预测性生物标志物
Palak R Parekh,Gregory M Botting,Denise B Thurber et al.
Palak R Parekh et al.
Background: Non-small cell lung cancer (NSCLC) is a leading cause of cancer deaths. Current companion diagnostics use driver mutation sequencing to select patients for molecularly targeted agents (MTA), even though most p...